These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 33435349)

  • 1. The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy.
    Tolomeo M; Cascio A
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 isoforms: Alternative fates in cancer?
    Aigner P; Just V; Stoiber D
    Cytokine; 2019 Jun; 118():27-34. PubMed ID: 30031681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma.
    Momtaz S; Niaz K; Maqbool F; Abdollahi M; Rastrelli L; Nabavi SM
    Biofactors; 2017 May; 43(3):347-370. PubMed ID: 27896891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT proteins as novel targets for cancer drug discovery.
    Turkson J
    Expert Opin Ther Targets; 2004 Oct; 8(5):409-22. PubMed ID: 15469392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3beta, a distinct isoform from STAT3.
    Zhang HX; Yang PL; Li EM; Xu LY
    Int J Biochem Cell Biol; 2019 May; 110():130-139. PubMed ID: 30822557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumorigenic potential of STAT3 alternative splicing modulation.
    Zammarchi F; de Stanchina E; Bournazou E; Supakorndej T; Martires K; Riedel E; Corben AD; Bromberg JF; Cartegni L
    Proc Natl Acad Sci U S A; 2011 Oct; 108(43):17779-84. PubMed ID: 22006329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligonucleotide-directed STAT3 alternative splicing switch drives anti-tumorigenic outcomes in MCF10 human breast cancer cells.
    Tano V; Jans DA; Bogoyevitch MA
    Biochem Biophys Res Commun; 2019 Jun; 513(4):1076-1082. PubMed ID: 31010684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Entinostat as a Novel Modifier of STAT3 Pre-mRNA Alternative Splicing.
    Kise M; Masaki S; Kataoka N; Suzuki K
    Biol Pharm Bull; 2024; 47(9):1504-1510. PubMed ID: 39284734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting transcription factor STAT3 for cancer prevention and therapy.
    Chai EZ; Shanmugam MK; Arfuso F; Dharmarajan A; Wang C; Kumar AP; Samy RP; Lim LH; Wang L; Goh BC; Ahn KS; Hui KM; Sethi G
    Pharmacol Ther; 2016 Jun; 162():86-97. PubMed ID: 26478441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors.
    Siveen KS; Sikka S; Surana R; Dai X; Zhang J; Kumar AP; Tan BK; Sethi G; Bishayee A
    Biochim Biophys Acta; 2014 Apr; 1845(2):136-54. PubMed ID: 24388873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small molecule compound targeting STAT3 DNA-binding domain inhibits cancer cell proliferation, migration, and invasion.
    Huang W; Dong Z; Wang F; Peng H; Liu JY; Zhang JT
    ACS Chem Biol; 2014 May; 9(5):1188-96. PubMed ID: 24661007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma.
    Zhang HF; Chen Y; Wu C; Wu ZY; Tweardy DJ; Alshareef A; Liao LD; Xue YJ; Wu JY; Chen B; Xu XE; Gopal K; Gupta N; Li EM; Xu LY; Lai R
    Clin Cancer Res; 2016 Feb; 22(3):691-703. PubMed ID: 26405196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule inhibitors of STAT3 for cancer therapy.
    Zhao M; Jiang B; Gao FH
    Curr Med Chem; 2011; 18(26):4012-8. PubMed ID: 21824090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development.
    Sgrignani J; Garofalo M; Matkovic M; Merulla J; Catapano CV; Cavalli A
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29843450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting STAT3 signalling in cancer: new and unexpected biological functions.
    Yu H; Lee H; Herrmann A; Buettner R; Jove R
    Nat Rev Cancer; 2014 Nov; 14(11):736-46. PubMed ID: 25342631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 and metabolism: how many ways to use a single molecule?
    Demaria M; Camporeale A; Poli V
    Int J Cancer; 2014 Nov; 135(9):1997-2003. PubMed ID: 24500994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.
    Wang H; Tao Z; Feng M; Li X; Deng Z; Zhao G; Yin H; Pan T; Chen G; Feng Z; Li Y; Zhou Y
    Biochem Biophys Res Commun; 2020 Dec; 533(3):368-375. PubMed ID: 32962858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo.
    Huang W; Dong Z; Chen Y; Wang F; Wang CJ; Peng H; He Y; Hangoc G; Pollok K; Sandusky G; Fu XY; Broxmeyer HE; Zhang ZY; Liu JY; Zhang JT
    Oncogene; 2016 Feb; 35(6):783-92. PubMed ID: 26073084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.
    Bharadwaj U; Kasembeli MM; Robinson P; Tweardy DJ
    Pharmacol Rev; 2020 Apr; 72(2):486-526. PubMed ID: 32198236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go?
    Huang Q; Zhong Y; Dong H; Zheng Q; Shi S; Zhu K; Qu X; Hu W; Zhang X; Wang Y
    Eur J Med Chem; 2020 Feb; 187():111922. PubMed ID: 31810784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.